Search PubMedSearch

PubMed · 8555570

A pumping artificial lung.

Abstract

The authors have developed a single device that performs the functions of a centrifugal pump and a membrane artificial lung. Unlike other systems that combine pre-existing components, our device is constructed so that the vanes of an impeller pump are made up of gas exchanging microporous fibers. The device has a variety of applications: in an easily primed emergency cardiopulmonary bypass circuit, as a low surface area component of extracorporeal life support (ECLS) circuits, and as a low volume, high perfusion rate bridge to transplant. Five prototype devices, with gas exchange surface areas ranging from 0.09 to 0.35 m2, have been tested in vitro to characterize the gas exchange and pumping capabilities of the device. These small devices pump fluid effectively. The larger device could pump 2.7 l/min with 91 mmHg pressure difference from inlet to outlet. These preliminary devices transferred to only 33 ml/min of oxygen (O2) and 35 ml/min of carbon dioxide (CO2), however. The combination of pumping ability and gas exchange is encouraging, but it is apparent that larger surface areas and less blood shunting around the gas exchanging impellers are needed for sufficient gas exchange. Somewhat higher surface areas are feasible within the pump-head casing used for these preliminary prototypes; larger casings could be used for still higher surface areas.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A J Makarewicz, L F Mockros, R W Anderson. A pumping artificial lung.. https://doi.org/10.1097/00002480-199407000-00054

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

There isn't an ideal smooth-surface material--yet: the history and future of urologic materials.

Indwelling and implantable urologic devices did not become commercially available until the late 1970s. The first such device was a ureteral stent made of silicone. Other materials-polyethylene, polyurethane, C-Flex, and Percuflex-have since been introduced. Each of these materials is rated for a particular indwell time, after which the material may begin to break down. Various methods of modifying the surface to make it more slippery or to prevent infection have been tested. Attempts have been made to create artificial organs and have not been entirely successful, and the future may lie with tissue-engineered materials such as small intestinal submucosa.

Artificial Organs

Tissue engineering of artificial organs.

Tissue engineering efforts are currently being undertaken for every type of tissue and organ within the urinary system. Most of the effort expended to engineer genitourinary tissues has occurred within the last decade. Tissue engineering techniques require expertise in growth factor biology, a cell culture facility designed for human application, and personnel who have mastered the techniques of cell harvest, culture, and expansion. Polymer scaffold design and manufacturing resources are essential for the successful application of this technology. In order to apply these engineering techniques to humans, further studies need to be performed with many of the tissues described. The first human application of cell-based tissue engineering technology for urologic applications took place at our institution, with the injection of autologous cells for the correction of vesicoureteral reflux in children. The same technology has been expanded to treat adult patients with urinary incontinence. Trials of urethral tissue replacement with processed collagen matrices are in progress, and bladder replacement using tissue engineering techniques are currently being arranged. Recent progress suggests that engineered urologic tissues may have clinical applicability in the future.

Artificial Organs

New multicomponent capsules for immunoisolation.

A new generation of microcapsules based on the use of oligomers which participate in polyelectrolyte complexation reactions has been developed. These freeze-thaw stable capsules have been applied as a bioartificial pancreas and have resulted in normoglycemia for periods of six months in concordant xenotransplantations. The new chemistry permits the control of permeability and mechanical properties over a wide range and can be adapted both to microcapsule and hollow fiber geometries rendering it a robust tool for encapsulation in general. Methods, and metrics, for the characterization of the mechanical properties and permeability of microcapsules are presented.

Artificial Organs